Theme Keynote Speakers
Theme 1 Keynote Speaker: Biomedical Signal Processing
Pierre-Alexandre Fournier is co-founder and CEO of Hexoskin, a Montreal-based company focused on clinical-grade wearable sensors and AI software for health and clinical research. He graduated in Electrical Engineering from École Polytechnique de Montréal in 2001 and completed a master’s degree in machine learning at the same university in 2005.
Mr. Fournier worked as an engineer for telecommunications, microelectronics, and artificial intelligence companies before founding Hexoskin with Jean-François Roy.
Hexoskin was founded in 2006 and launched in 2013 the first iPhone compatible smart clothing for health monitoring, which won several international awards. In 2018 Hexoskin launched a remote health monitoring system for astronauts to the International Space Station. The Hexoskin health sensors and software platform are used by hundreds of scientists around the world and have been used to collect data for more than 80 scientific publications.
Mr. Fournier is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.
Theme 4 Keynote Speaker: Computational Systems, Modeling and Simulation in Medicine, Multiscale Modeling & Synthetic Biology
Joelle Pineau is a faculty member at Mila and an Associate Professor and William Dawson Scholar at the School of Computer Science at McGill University, where she co-directs the Reasoning and Learning Lab. She is also co-Managing Director of Facebook AI Research, and the director of its lab in Montreal, Canada. She holds a BASc in Engineering from the University of Waterloo, and an MSc and PhD in Robotics from Carnegie Mellon University. Dr. Pineau’s research focuses on developing new models and algorithms for planning and learning in complex partially-observable domains. She also works on applying these algorithms to complex problems in robotics, health care, games and conversational agents. She serves on the editorial board of the Journal of Artificial Intelligence Research and the Journal of Machine Learning Research and is Past-President of the International Machine Learning Society. She is a recipient of NSERC’s E.W.R. Steacie Memorial Fellowship (2018), a Fellow of the Association for the Advancement of Artificial Intelligence (AAAI), a Senior Fellow of the Canadian Institute for Advanced Research (CIFAR), a member of the College of New Scholars, Artists and Scientists by the Royal Society of Canada, and a 2019 recipient of the Governor General’s Innovation Awards.
Theme 10 Keynote Speaker: Biomedical & Health Informatics
Adrian Schauer is the founder and CEO of AlayaCare, a healthtech start-up delivering the next disruptive solution for the home healthcare industry by combining remote patient monitoring, clinical documentation and back office software. Adrian is a serial technology entrepreneur having built two successful mobile software companies; both achieving leadership positions in their respective markets. Adrian is also an active Angel Investor and sits on the boards of several companies including fast growing technology firms like the point-of-care medical device company Chipcare, the SaaS company TrackTik, and the GRC software provider Resolver. Adrian is also the co-founder of the Madiro Fund, an organization created to support innovative solutions to the health problems in low income countries.
Prior to spinning Vortex Connect out as an independent company, Adrian had co-founded the market leading mobile marketing company Vortex Mobile where he was in charge of product strategy. Vortex Mobile was recognized for 2 consecutive years as one of Canada’s 50 Fastest growing companies by Profit Magazine and was acquired by Transcontinental in 2010.
Theme 3 Keynote Speaker: Micro/Nano-bioengineering; Cellular/Tissue engineering & Biomaterials
Maryam Tabrizian is James McGill Professor and Canada Research Chair nominee in Regenerative Medicine and Nanomedicine, cross-appointed between Faculty of Medicine-Biomedical Engineering Department and the Faculty of Dentistry. She became FRSQ-Chercheure nationale awardee (2006), Guggenheim Fellow in Biomedical Sciences (2010), the Fellow of the Biomaterials Science & Engineering (2011) and Fellow of Royal Society of Canada-Academy of Science (2017) for her contribution to the field of Biomedical Engineering and Biomedical Sciences. She has established expertise in the design of advanced biomaterials and biointerfaces for their application in nanomedicine, regenerative medicine and Lab-on-a-chip devices. She was the founding director of the Centre for Biorecognition and Biosensors (CBB) from 2003 to 2011. Professor Tabrizian is the author of over 235 peer-reviewed papers (H-index 60), 110 invited lectures,14 patents, and 340 communications. She is currently the Editor-in-Chief of Materials (MDPI ISSN 1996-1944), Regional Editor (North America) of Journal of Biomaterials and Tissue Engineering and Editorial Board of Journal of Biological Engineering.
Theme 8 Keynote Speaker: Biorobotics and biomechanics
Professor Sylvain Martel is Director of the Nanorobotics Laboratory and Professor in the Department of Computer and Software Engineering and the Institute of Biomedical Engineering at Polytechnique Montréal, Campus of the University of Montréal, as well as Adjunct Professor in the Department of Bioengineering at McGill University. He holds the Tier 1 Canada Research Chair in Medical Nanorobotics, acts as Chair of the IEEE Technical Committee on Micro- Nanorobotics and Automation, and he is Fellow of the Canadian Academy of Engineering, Fellow Engineers Canada as well as IEEE Fellow. He received many awards mostly in interdisciplinary research. While at the Department of Electrical Engineering and the Institute of Biomedical Engineering at McGill University and later in the Department of Mechanical Engineering at MIT prior to join Polytechnique Montréal, he developed several biomedical technologies including platforms for remote surgeries, cardiac mapping systems, and new types of brain implants for decoding neuronal activities in the motor cortex. Dr. Martel’s interdisciplinary research group is credited for the first demonstration of the controlled navigation of an untethered object in the blood vessel of a living animal. Since 2001, Prof. Martel’s research focus on developing new technologies for cancer therapy that enable the delivery of therapeutics directly to active cancer cells to maximize the therapeutic outcomes while minimizing toxicity for the patients. Prof. Martel is recognized worldwide as a pioneered and leading authority in the development of navigable therapeutic agents and novel interventional platforms for cancer therapy.